NEW YORK (GenomeWeb News) – Life Technologies last week filed a lawsuit against Promega alleging infringement of a US patent covering oligonucleotide labeling methods and compositions.

The suit was filed in the US District Court, Central District of California, Western Division and alleged that Promega is infringing US Patent Re-issue No. 43,096, titled, "Tagged Extendable Primers and Extension Products." The patent is a re-issue of US Patent No. 6,200,748 and covers the use of fluorescence to label oligonucleotides in genetic assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.